is glp 1 safe long term GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Agonists: A Comprehensive Overview

Early results are often subtle but gradually increase as the body responds to the medication

Why GLP-1 (semaglutide or tirzepatide) Might Be Particularly Relevant in Older Adults Cardiometabolic protection Large cardiovascular outcome trials (e.g., SELECT , SUSTAIN-6 ) show semaglutide reduces major adverse cardiovascular events (MACE), and subgroup analyses suggest these benefits extend to older patients

Targeting both types of receptors enhances tirzepatides effects on digestion and blood sugar, potentially explaining why it can be more effective than semaglutide

It is similar to Ipamorelin and Sermorelin in nature but has shown to be more effective at stimulating growth hormone production